Strains were maintained according to (Brenner, 1974) at 20°C, unless stated otherwise. The following Caenorhabditis elegans strains were used: wild-type (Bristol N2), HS::hlh-1 (KM267, (Fukushige and Krause, 2005) ),
unpublished). v) pax-1 promoter with a mutagenized FoxA site (SM1463). SM1463 carried an altered version of the 240 bp pax-1 promoter in which the PHA-4 binding site was mutated (PCR template bSEM438; T.F., J. Stevenson and S.E.M, unpublished) . Both SM1463 and SM1434 were injected with h2az::LacI::CFP (Updike and Mango, 2006) . vi) pax-1 promoter with a mutagenized positive regulator site (SM1564). SM1564 is 240 bp pax-1 fragment bearing an intact PHA-4 binding site but has a secondary mutation that abolishes transcription (PCR template bSEM430; T.F., J. Stevenson and S.E.M, unpublished) .
To determine copy number of promoters for NSA strains, worms were grown at restrictive temperature (25°), and treated with bleach to obtain synchronized embryos. NonCha-1 L3 animals from four plates were harvested for DNA isolation by phenol chloroform extraction and ethanol precipitation (Sambrook et al., 1989) . qPCR was performed for promoter regions and normalized to act-1 for quantitation. qPCR indicated a copy number of ≤200 for each promoter. We estimate the size of pseudochromosome arrays to be ~5-7Mb, based on (Stinchcomb et al., 1985) . This predicts there is approximately one promoter per 25 Kb.
Antibodies
Antibodies used in this study were anti-LacI MAb at 1:1000 (Upstate, #05-503), anti-PHA-4 PAb at 1:1000 (Horner, 1998), anti-H3K9me2 PAb at 1:500 (Upstate #07-441), anti-H3K9me3 PAb at 1:500 (Upstate #07-442), H5 MAb against RNA Polymerase II IgM at 1:50 (Kaltenbach et al., 2000) , Covance, #MMS-129R), anti-H3K27me3 (1:1000, Upstate # 07-449), 4C6.3 for the muscle marker (Fukushige and Krause, 2005) , 1CB4 for intestine (Okamoto and Thomson, 1985) and anti-HLH-1 (Krause et al., 1990 ).
Analysis of Wild-Type cDNA Samples for Integrity and Staging
The quality of the cDNA prepared from embryonic mRNA was assessed by examining three housekeeping genes, act-2, rpc-1 and mtr-4. The actin isoform act-2 is robustly expressed in the early embryo (Willis et al., 2006) , whereas expression of rpc-1 and mtr-4, which encode the large subunit of RNA polymerase III and nuclear exosomal RNA helicase respectively, are expressed at lower but constant levels from the 2-cell to the 8E stages (Baugh et al., 2003) . PCR was performed for the genes listed in Table S1 to confirm the staging of wild-type cDNA samples. Microarray data was submitted to the NCBI Gene Expression Omnibus, GEO #GSE14913. (Baugh et al., 2003) Criteria for Early, Transition and Differentiation Genes 1) Average changes in gene expression between 2-cell and 8E stages for Early and Differentiation genes, and between 2-cell and 2E-4E stages for Transition genes were ≥2-fold; 2) changes had an adjusted p-value <0.05 (Benjamini and Hocherg, 1995) ; 3) no expression above background was detected prior to the 2E stage for Transition genes or prior to the 8E stage for Differentiation genes; 4) no expression above background was detected for Early genes at the 8E stage. For 3) and 4), a gene was considered "off" if its Cy5 intensity level was below 2 7 , which was within 3-fold of the average minimum intensity ( Figure S3 ). Q-values (Storey and Tibshirani, 2003) were calculated to test for statistically significant differences in expression between wild-type versus mes-2 embryos.
Expression of candidate Early, Transition and Differentiation genes was compared with published microarray data (Baugh et al., 2003) and the RNA in situ database (http://nematode.lab.nig.ac.jp/db/index.html). Expression profiles of the majority of genes in these groups were in agreement with published data. Only 11% and 9% of Early and Transition genes, respectively, did not match the temporal expression seen in these other studies ( Figure S5A ). The number of not-confirmed genes was significantly higher in Differentiation group (29%, 21 genes); expression of 7 among 21 genes did not match published microarray data (Baugh et al., 2003) and in situ staining while 14 genes were assigned to the not-confirmed group only based on their in situ staining pattern. Since in situ hybridization is generally limited to relatively abundant mRNAs in C. elegans (Ogurusu and Shingai, 2002) , it might be too insensitive to detect low to moderately expressed differentiation genes, thus, explaining the high number of not confirmed genes in this group.
We also compared our lists of Early, Transition and Differentiation genes against the list germline genes (Reinke et al., 2004) . The Early gene group was enriched for germline genes (62%; Figure S5B ). This is in agreement with previously published data that found 53% of Maternal Declining (MD) genes, similar to our Early genes, were germline (Baugh et al., 2003) .
Nuclear Spot Assay
Transgenic worms were grown at 24°C, harvested, rinsed 3x with sterile H 2 O in 15 ml tubes and incubated with alkaline hypochlorite to release embryos. Embryos were washed 3x in sterile H 2 O and placed on microscope slides treated with 0.1% poly-L-lysine overnight (SigmaAldrich #P8920) and stained using standard approaches (Mango et al., 1994) .
Analysis of Gene Expression by RT-qPCR
2-cell embryos were collected from wild-type or mutant (mes-2, mes-3, mes-2; control(RNAi), mes-2; end-1(RNAi), or mes-2; pha-4(RNAi)) mothers and incubated at 20°C for 75 min. (2E), 120 min. (4E), 3h. (8E). 2-cell mes-1(ts) embryos were incubated at 25°C for 140 min (8E). Comparison of mutants with wild-type embryos showed equivalent cell cycle timing (T.Y., unpublished). cDNA from individual embryos were prepared by 50 cycles of amplification (Robertson et al., 2004 ; J. Priess, pers. comm) unless stated otherwise. For each stage, qPCR was carried out in duplicate using a cDNA sample from three pooled wild-type or mutant embryos using a LightCycler ® PCR machine with LightCycler ® FastStart DNA Master Plus SYBR Green 1 kit (Roche). Data was normalized to two reference genes, C30B5.4 or act-2, for quantitation.
Table S2. Proportion of Florets, Crescents, and Ellipsoids in Early Embryos
Arrays bearing wild-type (WT) promoters or promoters mutated for PHA-4 binding sites (myo-2 mut.P, pax-1 mut.P) or for an independent activation site (pax-1 mut.A1) were analyzed. The mutations in pax-1 block expression (T.F., Jeff Stevenson and S.E.M, unpublished), the mutations in myo-2 inhibit PHA-4 regulation (Gaudet and Mango 2002) . Embryos were staged by counting the total number of cells per embryo with Volocity software. For wildtype myo-2, pax-1 and C44H4.1, the linear regression trend for the loss of florets from the 2E to the 8E stages was statistically significant (p ≤ 10 -19 for each).
%Crescents Stage myo-2 WT myo-2 mut.P pax-1 WT pax-1 mut.P pax-1 mut.A1 C44H4.1 WT No Target  2E  0%  6%  5%  8%  5%  1%  4%  4E  30%  34%  23%  34%  18%  28%  26%  8E  51%  51%  66%  43%  45%  31% Figure S1 . Equivalent HLH-1 Expression in Heat-Shock-Treated Mes-2(+/-) and Mes-2(-) Embryos by Qpcr and Antibody Staining A) Levels of hlh-1 expression in control and mutant embryos were determined by RT qPCR. HS::hlh-1 embryos were heat-shocked at the 8E stage as described (Kiefer et al., 2007) and incubated for 25 min at 20°C prior to harvesting and mRNA isolation (Robertson et al., 2004) . qPCR was carried out in duplicate for 19 cDNA samples prepared from 10 individual mes-2(+/-) and 9 individual mes-2(-) embryos. Averages for each sample were normalized to the reference gene C30B5.4 and plotted on a log 2 scale. The difference in hlh-1 expression between control and mutant samples was not statistically significant using a paired T-test (pvalue >0.5). B) Control and mutant embryos heat-shocked at the 8E stage as described above were stained with anti-HLH-1 antibody (Krause et al., 1990) and DAPI. Representative images for mes-2(+/-) and mes-2(-) embryos are shown.
Figure S2. Loss of Pha-4 Does Not Lead to Prolonged Developmental Plasticity upon Induction of Body Wall Muscle Fate
Embryos collected from heterozygous pha-4 (+/-) mothers were challenged to adopt body muscle fate by ectopic expression of HS::hlh-1 at the 2E stage. After development, embryos were stained for PHA-4 (foregut) and paramyosin (muscle). 25% of these embryos were expected to be pha-4(-). A) Embryos with widespread vs. localized expression of body wall muscle marker were counted, n=31 widespread and n=13 localized,. B) Of embryos with localized body wall muscles, we expected 25% of these to be pha-4(-) (or 3.25 of 13, dotted line), if mutant embryos behaved like wild-type embryos. Instead, 39% of embryos in this group were negative for PHA-4 (n=5 of 13; red line), indicating more resistant embryos were pha-4(-). These data indicate that pha-4 mutants were less plastic than control embryos at the 2E stage, similar to the findings with HS::end-1 shown in Figure 1 .
Figure S3. Criteria Used to Assign Wild-Type Genes to Early, Transition or Differentiation Groups.
Wild-type genes were assigned to Early, Transition or Differentiation groups based on the following criteria: 1) Early genes were expressed in embryos at the 2-cell and 2E stages, and down-regulated at least 2-fold by the 8E stage to background levels. Changes in expression from 2-cell to the 8E stage were statistically significant, with Benjamini and Hochberg (1995) adjusted p-values <0.05. 2) Transition genes were transiently expressed at the 2E-4E stages, and downregulated at least 2-fold by the 8E stage. Changes in expression from 2-cell to the 2E or 4E stages were at least 2-fold and they were statistically significant with adjusted p <0.05. 3) Differentiation genes were expressed at the onset of differentiation, at the 8E stage. No expression was detected prior to that. Changes in expression from the 2-cell to the 8E stage were at least 2-fold, and they were statistically significant with adjusted p-values <0.05. Generally, a gene was considered to be expressed ("on") when its Cy5 intensity level reached at least 2 7 (shown as a dotted line), which was 3-fold above the average minimum intensity.
Figure S4. Early, Transition and Differentiation Genes in Wild-Type Embryos
Expression profiles of Early (A), Transition (B) and Differentiation (C) genes at the 2E, 4E and 8E stages. Normalized average intensity from three independent experiments plotted on a log 2 scale. Classification of Early (D), Transition (E) and Differentiation (F) genes according their COG titles (www.wormbase.org); genes lacking homologues comprised 60%, 46% and 52% of Early, Transition and Differentiation genes, respectively and were excluded.
Figure S5. Validation of Identified Genes by Published Data
(A)Expression of candidate Early, Transition or Differentiation genes was compared with the RNA in situ database (http://nematode.lab.nig.ac.jp/db/index.html) and published microarray data (Baugh et al., 2003) . Genes were assigned into "confirmed" or "not confirmed" categories based on agreement of their expression profiles with these sources. Poorly characterized genes were assigned into the "no data" category.
(B) The list of genes in each group was compared against the list of intrinsic germline genes (Reinke et al., 2004) , and the percent of germline genes in each group graphed.
Figure S6. qPCR Verification of Selected Early Genes
For each stage qPCR was carried out in duplicate on cDNA from three pooled wild-type or mes-2 embryos collected at the 2E, 4E or 8E stages and prepared with 50 rounds of amplification (wild-type, green; mes-2, red, according to (Robertson et al., 2004) ). Additionally, qPCR was performed on a pool of cDNAs from 3 additional pooled mes-2 embryos collected at the 8E stage and prepared with 35 rounds of amplification (mes-2 (35), blue, according to (Robertson et al., 2004) ). Averages from each experiment were normalized to the reference gene C30B5.4, and plotted on a linear scale. Microarray expression profiles for 10 out of 11 (91%) randomly selected Early genes were confirmed by qPCR in wild-type (50) and mes-2 (50) cDNA samples. qPCR performed on a mes-2 (35) cDNA sample confirmed upregulation for 8 of these genes (73%) in 8E mes-2 embryos.
Figure S7. qPCR Verification of Selected Differentiation Genes
For each stage qPCR was carried out in duplicate on a pool of cDNAs from 3 individual wildtype or mes-2 embryos collected at the 2E, 4E or 8E stages and prepared with 50 rounds of amplification (wild-type, green; mes-2, red). Additionally, qPCR was performed on a pool of cDNAs from 3 other individual mes-2 embryos collected at the 8E stage and prepared with 35 rounds of amplification (mes-2 (35), blue) to avoid false positives. Averages from each experiment were normalized to the reference gene C30B5.4 and plotted on a linear scale. Microarray expression profiles of all randomly selected differentiation genes were confirmed by qPCR for wild-type (50) and mes-2 (50) cDNA samples. qPCR performed on a mes-2 (35) cDNA sample confirmed down-regulation of 9 of these genes (90%) in 8E mes-2 embryos. (B) Gene expression across the whole genome in wild-type and mes-2 embryos at the 2E or 8E stages was analyzed using Genesifter (www.genesifter.net)). Genes with statistically significant changes in their expression levels in mes-2 mutants (adjusted p<0.05, n=52 at the 2E stage, n=2651 at the 8E stage) were assigned to chromosomes, and their chromosomal distribution is shown. Both regions are relatively gene-dense, with 18 genes predicted for the 128Kb myo-2 region and 28 genes for the 93Kb pax-1 domain. Arrows denote the direction of transcription. Given the role of transcription for altering chromatin condensation, we considered whether transcription of genes within the myo-2 or pax-1 regions could account for changes in morphology. For each gene with detectable expression, boxes in the upper panels represent expression in wild-type embryos at the 2E, 4E and 8E stages (left to right). The level of wildtype expression at the 2E stage served as a reference (black circle). Down-regulation or upregulation of gene expression relative to each reference is shown in green or red, respectively; the brightest shade represents ≥2-fold difference. Boxes in the lower panels represent expression in mes-2 embryos at corresponding stages. Stages where the difference between wild-type and mes-2 microarray expression was statistically significant (q-value <0.05) (Storey and Tibshirani) are marked with asterisks. T18D3.6 and T18D3.7 in the myo-2 region, were not expressed in wild-type embryos (marked as "low") but were up-regulated at the 8E stage in mes-2 mutants compared to the 2E stage.
Figure S13. Compaction of Endogenous Chromatin in mes-2(+/-) Embryos
Mean-square 3D-distances between FISH probes were calculated as in (Chambeyron and Bickmore, 2004) . Plots represent the distribution of 3D-distances (µm 2 ) for myo-2 and pax-1 regions in mes-2 (+/-) 2E and 8E embryos. Averages for each experiment are shown as dotted red lines.
